Vaxart, Inc. 8-K

What Happened
Vaxart, Inc. (VXRT) announced its financial results for the year ended December 31, 2025 via a press release issued March 12, 2026. The company furnished the press release as Exhibit 99.1 to a Current Report on Form 8‑K (Item 2.02: Results of Operations and Financial Condition). The filing states that the information is being furnished (not “filed”) and therefore is not subject to Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act; quotes by Steven Lo included in the press release are explicitly not incorporated by reference.

Key Details

• Filing date: March 12, 2026; reporting period covered: year ended December 31, 2025.
• Press release attached as Exhibit 99.1 to the Form 8‑K.
• Information furnished, not filed — limits certain liabilities and does not automatically become incorporated into future SEC filings.
• Item reported: 2.02 (Results of Operations and Financial Condition); the filing also includes an Inline XBRL cover page (Exhibit 104).

Why It Matters
This 8‑K is the company’s official public announcement of its full‑year 2025 earnings and financial condition. Retail investors should read the attached press release for specific figures on revenue, net income/loss, cash position and guidance (if provided), and watch for the company’s subsequent periodic filings (e.g., Form 10‑K) or investor calls for more detail. Because the release is furnished rather than filed, investors should rely on the press release and follow‑up filings for the definitive financial disclosures.